This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Looking at Roche's SBX Technology and how it is differentiated in the Next-Generation-Sequencing (NGS) space

Ticker(s): RHHBY, ILMN, PACB, TXG, BRKR, Ultima Genomics, element biosciences

Who's the expert?

Institution: Robert Wood Johnson School of Medicine

Bio:

  • Bioinformatics lead for the Genome Sequencing Core, responsible for all of the computational aspects of genetic sequencing being performed
  • Familiar with all of the current sequencing technologies including, Illumina, Pacific Bioscience, Ion Torrent, Complete Genomics, and Oxford Nanopore.  He is an expert in the use of genomics for cancer, fertility pediatric disease, forensics and diagnostics.
  • Provided expert advice for the BRCA1 patent litigation

Interview Questions
Q1.

Describe your background and research setting

Added By: ben_admin
Q2.

What different systems do you utilize for DNA Sequencing?

Added By: ben_admin
Q3.

What is your opinion on the potential of the SBX Technology from Roche?

Added By: ben_admin
Q4.

How is the SBX system different from other systems on the market?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.